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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of yoga on health-related quality of life, mental health, and cancer-related symptoms in women diagnosed with
breast cancer who are on active treatment or have completed treatment.
B A C K G R O U N D
Description of the condition
With more than 1.3 million new cases each year, breast cancer is
the most frequently diagnosed cancer in women worldwide (Ferlay
2010). While still more than 450,000 women will die from breast
cancer each year (Ferlay 2010), advances in cancer prevention, di-
agnosis, and treatment have led to a continuous increase in sur-
vival rates (Berry 2005). During breast cancer treatment, about
one third of women experience substantial psychological distress,
mainly depression and anxiety (Stafford 2013), that does not sig-
nificantly decrease over time (Hopwood 2010). These psycholog-
ical impairments can aggravate symptom burden and seriously af-
fect health-related quality of life (Andrykowski 2008). Cancer-re-
lated fatigue is another important symptom that interferes with
usual functioning (Patrick 2003). Up to 90% of women with
breast cancer experience fatigue during chemotherapy (Hartvig
2006; Schmidt 2012), which may endure for several years (Bower
2006; Garabeli Cavalli Kluthcovsky 2012). Sleep disturbance is
also highly prevalent in women with breast cancer, prior to surgery,
during subsequent chemotherapy (Van Onselen 2012), and dur-
ing anti-hormonal treatment (Desai 2013).
Description of the intervention
Yoga has its roots in Indian philosophy and has been a part of tra-
ditional Indian spiritual practice for about 4000 years (Feuerstein
1998). Being a complex intervention, yoga comprises advice for
an ethical lifestyle, spiritual practice, physical activity, breathing
exercises, and meditation (De Michaelis 2005; Feuerstein 1998).
While yoga originally evolved as a spiritual practice, it has be-
come a popular means to promote physical and mental well-being
(De Michaelis 2005; Feuerstein 1998). In North America and Eu-
rope, yoga is most often associated with physical postures (asanas),
breathing techniques (pranayama), and meditation (dyana) (De
Michaelis 2005; Feuerstein 1998). Contrary to popular percep-
tions, meditation and breathing techniques are inherent parts of
yoga practice. Different yoga forms have emerged that put varying
focus on physical and mental practices (Feuerstein 1998). While
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most yoga forms practised in North America and Europe mainly
focus on postures, many yoga traditions only include meditation
(Shannahoff-Khalsa 2005) or breathing techniques (Brown 2005)
without specific physical components. An estimated 15 million
American adults report having practised yoga at least once in their
lifetime, almost half of these adults use yoga explicitly for coping
with disease or promoting health (Saper 2004).
How the intervention might work
It is now widely accepted that therapeutic exercise programs for
women diagnosed with breast cancer who are on active treatment
or have completed treatment can significantly improve physical
functioning and quality of life, and mitigate fatigue (McNeely
2006; Visovsky 2006). In addition, exercise decreases the percent-
age of body fat, improves cardiopulmonary function (Kim 2009;
McNeely 2006), and decreases mortality rates in women who have
completed treatment for breast cancer (Ibrahim 2011). Physical
exercise reduces the blood insulin level (Irwin 2009), strength-
ens the immune system, and promotes the catabolism of stress
hormones and oestrogens (Neilson 2009). Furthermore, exercis-
ing together in a group of similarly affected women should en-
hance the individual’s quality of life (Floyd 2009). While yoga in-
volves physical activity, it differs from purely gymnastic exercise in
that the practitioner focuses her mind on the postures with inner
awareness and a meditative focus of mind (Büssing 2011; Cramer
2013). A proposed mechanism of how yoga could positively influ-
ence mental and physical health is a decrease of dysregulation in
the hypothalamic-pituitary-adrenal axis; this is the stress response
(Carroll 2012; Streeter 2012). Yoga can decrease subjective stress
in healthy adults (Chong 2011) and reduce levels of plasma corti-
sol in individuals with cancer (Banasik 2011; Vadiraja 2009) and
psychiatric patients (Devi 1986; Vedamurthachar 2006). Imaging
studies have shown that yoga can increase endogenous dopamine
release in the ventral striatum (Kjaer 2002) and thalamic gamma-
aminobutyric acid (GABA) levels (Streeter 2010). Both dopamine
(Syvälahti 1994) and GABA (Kalueff 2007) play a major role in
the pathophysiology of psychological distress. It has been hypoth-
esised that by increasing GABA activity, yoga can reduce allostatic
load in stress response systems such that optimal homeostasis is
restored (Streeter 2012).
Why it is important to do this review
Many women who are currently undergoing treatment or
have completed treatment for breast cancer use complemen-
tary medicine (NIH 2012) to manage the effects of the disease
(Fouladbakhsh 2010), and yoga is among the most commonly used
complementary therapies for breast cancer-related impairments
(Fouladbakhsh 2010). Systematic reviews and meta-analyses have
shown that yoga can improve health-related quality of life in cancer
patients (Buffart 2012; Culos-Reed 2012; Lin 2011; Smith 2009).
However, as individuals with different types of cancer are hetero-
geneous in terms of socio-demographic factors, symptoms, treat-
ment and side effects, meta-analyses should focus on homogenous
cancer groups. It is obvious from previous reviews that the vast ma-
jority of studies on yoga for cancer have involved women on active
treatment or who have completed treatment for breast cancer. Four
systematic reviews so far have explicitly focused on women under-
going treatment or who have completed treatment for breast can-
cer (Cramer 2012; Harder 2012; Levine 2012; Zhang 2012) and
only two of these included meta-analyses (Cramer 2012; Zhang
2012). Based on six randomised trials that compared yoga to no
treatment, Zhang 2012 found significant effects favouring yoga on
health-related quality of life but not on psychological outcomes.
In contrast, Cramer 2012 found positive effects of yoga compared
to no treatment or active control interventions on health-related
quality of life, depression, and anxiety. Besides health-related qual-
ity of life and mental health, only one prior review assessed phys-
ical cancer-related symptoms and this review did not include a
meta-analysis (Harder 2012). Evidence for effects on fatigue was
inconclusive, with three out of seven included trials reporting pos-
itive effects of yoga.
Mainly based on anecdotal evidence, the safety of yoga has been
questioned in the lay press (Broad 2012). As this seems to have
led to a general uncertainty among yoga practitioners and those
interested in starting practice, it seems important to systematically
assess the safety of yoga. However, no prior review on yoga for
women with breast cancer has quantitatively analysed safety data.
Therefore, a comprehensive review of both the efficacy (in terms
of health-related quality of life, physical and mental health) and
safety of yoga for women undergoing active treatment or who have
completed treatment for breast cancer seems warranted.
O B J E C T I V E S
To assess the effects of yoga on health-related quality of life, mental
health, and cancer-related symptoms in women diagnosed with
breast cancer who are on active treatment or have completed treat-
ment.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (RCTs) assessing the effects of
yoga in women with breast cancer undergoing treatment or who
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have completed treatment, or both. Both full text and abstract
publications will be eligible if sufficient information is available
on study design, characteristics of participants, interventions, and
outcomes.
Types of participants
Women with a histologically confirmed diagnosis of non-
metastatic or metastatic breast carcinoma (Stage I - IV) as de-
fined by the American Joint Committee on Cancer (AJCC) tu-
mor-node-metastasis (TNM) system (Compton 2012).
Women diagnosed with breast cancer and who have completed
treatment (that is, completed initial management of Stage I - IV
breast cancer) will also be eligible.
No limits will be applied regarding age groups or settings.
Studies including participants with other cancer types will be ex-
cluded unless the outcomes for the breast cancer subgroup are re-
ported separately.
Types of interventions
Any form of yoga will be eligible as the experimental intervention
(for example Hatha yoga, Ashtanga yoga, Iyengar yoga, Integrated
yoga therapy, Viniyoga, Bikram Yoga, Sivananda yoga, Kundalini
yoga, Tibetan yoga, Yoga of Awareness, or any other yoga form).
Studies that do not mention a specific form of yoga but simply de-
scribe their intervention as ’yoga’ will also be eligible. Interventions
should include at least one of the following: yoga postures, breath
control, meditation, and lifestyle advice (based on yoga theory or
traditional yoga practices).
Studies on multimodal interventions such as mindfulness-based
stress reduction, mindfulness-based cognitive therapy, or the Mind
Body Program for Cancer by the Benson-Henry Institute for Mind
Body Medicine (that includes yoga amongst other therapies) will
be excluded as the relative effects of yogic practices cannot be
assessed separately in such programs.
Attention control, waiting list control, treatment as usual, no ther-
apy, or any other active therapy will be eligible as the comparator.
Breast cancer treatments such as chemotherapy, radiotherapy, or
anti-hormonal therapy, and supportive care will be allowed as long
as the co-interventions are intended to be comparable between
groups.
Types of outcome measures
Primary outcomes
• Health-related quality of life, assessed by any validated
generic or disease-specific self-report scale
• Depression, assessed by any validated self-report or
clinician-rated scale
• Anxiety, assessed by any validated self-report or clinician-
rated scale
• Fatigue, assessed by any validated self-report scale
• Sleep disturbances, assessed by any validated self-report scale
When there is more than one measure for an outcome, standard
instruments will be preferred over novel instruments and multi-
item instruments over single-item instruments.
Secondary outcomes
• Safety of the intervention, assessed as number of women
with adverse effects and number of women with severe adverse
events
Search methods for identification of studies
Electronic searches
We will search the following databases.
(a) Cochrane Breast Cancer Group (CBCG) Specialised Register.
Details of search strategies used by the CBCG for the identifica-
tion of studies and the procedures used to code references are out-
lined in the CBCG’s module at www.mrw.interscience.wiley.com/
cochrane/clabout/articles/BREASTCA/frame.html. Trials with
the key words “breast cancer”, “early breast cancer”, “locally
advanced breast cancer”, “advanced breast cancer”, “high risk”,
“yoga”, and “alternative/complementary therapy” will be extracted
and considered for inclusion in the review.
(b) MEDLINE (via PubMed). See Appendix 1.
(c) EMBASE (via EMBASE.com). See Appendix 2.
(d) World Health Organization (WHO) International Clin-
ical Trials Registry Platform (ICTRP) search portal (http://
apps.who.int/trialsearch/Default.aspx) for all prospectively regis-
tered and ongoing trials. See Appendix 3.
(e) Clinicaltrials.gov (http://clinicaltrials.gov/). See Appendix 4.
(f ) IndMED (http://indmed.nic.in/indmed.html). See Appendix
5.
(g) CENTRAL (2013, Issue 3). See Appendix 6.
Searching other resources
(a) Bibliographic searching.
We will try to identify further studies from reference lists of iden-
tified relevant trials or reviews. A copy of the full article will be
obtained for each reference reporting a potentially eligible trial.
Where this is not possible, attempts will be made to contact au-
thors for them to provide additional information.
(b) Grey literature searching.
Conference proceedings of the following congresses and annual
meetings of societies will be searched for relevant abstracts:
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• International Congress on Complementary Medicine
Research (ICCMR);
• European Congress for Integrative Medicine (ECIM);
• American Society of Clinical Oncology (ASCO).
Data collection and analysis
Selection of studies
Titles and abstracts of studies identified during the literature search
will be screened independently by two review authors (HC and
RL). Potentially eligible articles will be read in full by two review
authors (HC and RL) to determine whether or not they meet the
eligibility criteria. Disagreements will be discussed with a third
review author (PK) until consensus is reached. If necessary, addi-
tional information will be obtained from the study authors.
Excluded studies will be recorded in the ’Characteristics of ex-
cluded studies’ table.
The study selection process will be documented in a PRISMA flow
chart (Moher 2009).
No language restrictions will be applied. Studies in languages
other than English, German, French, Russian, Chinese, Norwe-
gian, Swedish, or Islandic will be professionally translated.
Data extraction and management
Two review authors (PK and SL) will independently extract and
enter data from all included studies into the ’Characteristics of
included studies’ table in the Review Manager software (RevMan).
Disagreements will be discussed with a third review author (HC)
until consensus is reached. A third review author (HC) will check
the extracted data.
The information collected will include the following.
• Methods: study design, methods of allocation, allocation
concealment, blinding, dropout rates and reasons for dropping
out.
• Participants: country of origin, setting, sample size,
diagnosis, age, ethnicity.
• Intervention: type, program length, frequency, duration
(for experimental and comparator interventions).
• Outcomes: type of outcomes, assessment instruments,
assessment time point, and follow-up time point.
For studies with more than one publication, the first publication
will be considered as the primary reference but data will be ex-
tracted from all of the publications.
Assessment of risk of bias in included studies
Two review authors (PK and SL) will independently assess risk of
bias using Cochrane’s risk of bias assessment tool (Higgins 2011).
Risk of bias will be assessed for the following domains.
• Random sequence generation.
• Allocation concealment.
• Blinding of participants and personnel.
• Blinding of outcome assessment.
• Incomplete outcome data.
• Selective outcome reporting.
• Other sources of bias.
Each domain will be judged as either:
• ’low risk of bias’ if the requirements are adequately fulfilled,
as described in Higgins 2011;
• ’high risk of bias’ if the requirements are not adequately
fulfilled, as described in Higgins 2011;
• ’unclear risk of bias’ if insufficient data for a judgement are
provided.
Risk of bias will be incorporated in judging the quality of evidence
for each outcome according to the GRADE recommendations
(Guyatt 2008).
Measures of treatment effect
Primary outcomes will be classified as continuous outcomes and
expressed as standardised mean differences (SMD) with 95% con-
fidence intervals (CI) according to the Cochrane Handbook for Sys-
tematic Reviews of Interventions, chapter 7, section 7.7.3 (Higgins
2011). SMD will be calculated as the difference in means between
groups divided by the pooled standard deviation using Hedges’
correction. Where available, final values will be preferred over
change scores. A positive SMD will be defined to indicate ben-
eficial effects of the experimental intervention compared to the
comparator intervention for quality of life, while a negative SMD
will be defined to indicate beneficial effects for mental health and
cancer-related symptoms. If necessary, scores will be inverted by
subtracting the mean from zero (Higgins 2011).
Secondary outcomes will be classified as dichotomous outcomes
and expressed as risk ratios (RR) with 95% CI. RR will be calcu-
lated by dividing the risk of an event in the experimental group
(that is the number of participants with the respective outcome
divided by the total number of participants) by the risk of the
event in the control group. RRs less than 1.0 will be defined to
favour the experimental group (that is fewer adverse events than
in the comparator group) and RRs greater than 1.0 will be defined
to favour the comparator group (Higgins 2011).
Unit of analysis issues
Special issues in the analysis of studies with non-standard designs
will be handled according to the suggestions of the Cochrane Hand-
book for Systematic Reviews of Interventions (Higgins 2011). For
cross-over trials, paired data will be analysed if available. Elsewise,
only data from the first active treatment phase will be used. If
repeated outcome assessments are presented, the time frames will
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be defined as short term (up to six months), medium term (six
to 12 months), and long term follow-up (more than 12 months).
For studies that contribute multiple, correlated comparisons, all
relevant experimental intervention groups of the study (for exam-
ple groups with yoga interventions of different intensities) will be
combined into a single group and all comparable relevant control
intervention groups (for example groups with exercise interven-
tions of different intensities) will be combined into a single control
group. Control groups with different types of interventions (for
example waiting list control and exercise) will not be combined in
a single meta-analysis but analysed separately.
Dealing with missing data
Where standard deviations are missing, they will be calculated
from standard errors, confidence intervals, or t values, or attempts
will be made by e-mail to obtain the missing data from the trial
authors (Higgins 2011). If these data are not available, the missing
standard deviation will be substituted with the mean of the stan-
dard deviations of available studies which used the same outcome
scale. Where means are missing, attempts will be made by e-mail
to obtain the missing data from the trial authors.
Sensitivity analyses will be conducted by excluding studies where
missing data had to be substituted (see below).
The potential impact of missing data on the findings of the review
will be discussed in the ’Discussion’ section.
Assessment of heterogeneity
Statistical heterogeneity between studies will be assessed using the
Chi2 test (Cochran 1954). A P value ≤ 0.10 will be regarded
to indicate significant heterogeneity. Additionally, the I2 statistic
(Higgins 2003) will be used. The magnitude of heterogeneity will
be categorized as: I2 = 0% to 24%, low heterogeneity; I2 = 25%
to 49%, moderate heterogeneity; I2 = 50% to 74%, substantial
heterogeneity; and I2 = 75% to 100%, considerable heterogeneity.
Assessment of reporting biases
If at least 10 studies are included in a meta-analysis, funnel plots of
effect estimates against their standard errors (on a reversed scale)
will be generated using Review Manager software (RevMan). Pub-
lication bias will be assessed by visual analysis of funnel plots,
with roughly symmetrical funnel plots indicating low risk and
asymmetrical funnel plots indicating high risk of publication bias
(Higgins 2011). One should be aware that funnel plot asymmetry
might also arise from other sources, and that publication bias need
not lead to asymmetry in the funnel plots. Further attempts will
be made to avoid publication bias by searching trial registries and
conference proceedings for unpublished studies.
Duplicate publication bias will be addressed as studies with more
than one publication will be included only once. If there is doubt
whether multiple publications refer to the same data, attempts will
be made to contact the trial authors by e-mail.
Location bias will be addressed by searching multiple databases,
including one of Indian journals, and by including non-English
language journals.
Language bias will be avoided by including studies irrespective of
the language of publication.
Data synthesis
For continuous outcomes, data will be pooled using a random-
effects model (inverse variance method). For dichotomous out-
comes, a random-effects model (DerSimonian and Laird) will be
used. All analyses will be performed using RevMan 5 software
(RevMan).
To grade the quality of evidence, the GRADE approach will be
used (Brozek 2009). The software GradePro will be used. A ’Sum-
mary of findings’ table will be created to present the evidence for
the primary outcomes (health-related quality, depression, anxiety,
fatigue, and sleep disturbances).
Subgroup analysis and investigation of heterogeneity
Subgroup analyses will be conducted for the following.
I) Current treatment status:
1. women with breast cancer undergoing active cancer
treatment (radiotherapy or chemotherapy);
2. women who have completed active treatment.
II) Time since diagnosis:
1. women with breast cancer diagnosed ≤ five years before
time of study entry;
2. women with breast cancer diagnosed > five years before
time of study entry.
III) Stage of cancer:
1. metastatic breast cancer at time of study entry;
2. non-metastatic breast cancer at time of study entry.
Further subgroup analyses will be conducted for the type of yoga
intervention:
1. complex yoga interventions including physical exercise and
at least one of the following: breath control, meditation, and
lifestyle advice (based on yoga theory or traditional yoga
practices);
2. exercise-based yoga interventions (based on yoga theory or
traditional yoga practices) without breath control, meditation, or
lifestyle advice;
3. meditation-based yoga interventions including at least one
of the following: breath control, meditation, and lifestyle advice
(based on yoga theory or traditional yoga practices) without an
exercise component.
Subgroup differences will be tested using the Chi2 test for hetero-
geneity across subgroups. The I2 statistics for subgroup differences
will be computed as the percentage of the variance between the
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different subgroups that is due to genuine subgroup differences
rather than chance (Higgins 2011).
If statistical heterogeneity is present in the respective meta-analy-
sis, subgroup and sensitivity analyses will also be used to explore
possible reasons for the heterogeneity.
Sensitivity analysis
Sensitivity analyses will be performed by subsequently excluding
studies with inadequate random sequence generation, studies with
inadequate allocation concealment, studies without blinding of
outcome assessors, and studies with high risk of attrition bias.
Further sensitivity analyses will be performed by excluding studies
where missing data had to be substituted and by excluding studies
that were unpublished or published only in abstract format.
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#9 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8
#10 breast neoplasms [mh]
#11 breast neoplasm* [tiab]
#12 breast cancer [tiab]
#13 breast carcinoma* [tiab]
#14 breast tumor* [tiab]
#15 mamma carcinoma* [tiab]
#16 mammary neoplasm* [tiab]
#17 mammary carcinoma* [tiab]
#18 mammary gland carcinoma* [tiab]
#19 #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18
#20 randomized controlled trial [pt]
#21 controlled clinical trial [pt]
#22 randomized [tiab]
#23 placebo [tiab]
#24 clinical trials as topic [mesh: noexp]
#25 randomly [tiab]
#26 trial [ti]
#27 #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26
#28 Search #7 AND #17 AND #25
#29 Search animals[mh] NOT humans[mh]
#30 Search #26 NOT #27
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Appendix 2. EMBASE
#1
randomised AND controlled AND trial
#2
randomized AND controlled AND trial
#3




















’breast tumor’/exp OR ’breast tumor’
#14
’breast carcinoma’/exp OR ’breast carcinoma’
#15
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#24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30
#32
#9 AND #23 AND #29
#33
#30 AND [humans]/lim AND [embase]/lim
Appendix 3. WHO ICTRP search portal
Basic searches:
1. Yoga for women with breast cancer and breast cancer survivors
2. Breast cancer AND yoga
3. Breast cancer survivors AND yoga
Advanced searches:
1. Title: Yoga for women with breast cancer and breast cancer survivors
Recruitment Status: ALL
2. Condition: breast cancer
Intervention: yoga OR yogic OR meditation OR asana OR pranayama OR dharana OR dhyana
Recruitment Status: ALL
3. Condition: breast cancer survivor*
Intervention: yoga OR yogic OR meditation OR asana OR pranayama OR dharana OR dhyana
Recruitment Status: ALL
4. Condition: breast cancer AND survivor





1. Yoga for women with breast cancer and breast cancer survivors
2. Breast cancer AND yoga
3. Breast cancer survivors AND yoga
Advanced searches:





2. Condition: breast cancer
Intervention: yoga OR yogic OR meditation OR asana OR pranayama OR dharana OR dhyana
Recruitment: ALL
Study Results: ALL
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Study Type: ALL
Gender: ALL
3. Condition: breast cancer survivor





4. Condition: breast cancer AND survivor






(yoga OR yogic OR meditation OR asana OR asanas OR pranayama OR dharana OR dhyana) AND (breast neoplasm OR breast
neoplasms OR breast cancer OR breast carcinoma OR breast carcinomas OR breast tumor OR breast tumors OR mamma carcinoma
OR mamma carcinomas)
Appendix 6. CENTRAL
#1 MeSH descriptor: [Breast Neoplasms] explode all trees
#2 breast cancer survivor*
#3 #1 or #2
#4 yoga or yogic or meditation or asana or pranayama or dharana or dhyana
#5 #3 and #4
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